A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F

SR Chen, Y Dai, J Zhao, L Lin, Y Wang… - Frontiers in …, 2018 - frontiersin.org
Triptolide and celastrol are predominantly active natural products isolated from the
medicinal plant Tripterygium wilfordii Hook F. These compounds exhibit similar …

Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol

Y Lu, Y Liu, J Zhou, D Li, W Gao - Medicinal research reviews, 2021 - Wiley Online Library
Celastrol, a quinone‐methide triterpenoid, was extracted from Tripterygium wilfordii Hook. F.
in 1936 for the first time. Almost 70 years later, it is considered one of the molecules most …

Celastrol and Resveratrol Modulate SIRT Genes Expression and Exert Anticancer Activity in Colon Cancer Cells and Cancer Stem-like Cells

H Moreira, A Szyjka, J Grzesik, K Pelc, M Żuk, A Kulma… - Cancers, 2022 - mdpi.com
Simple Summary The recovery rate in patients with metastatic colorectal cancer (CRC)
remains low and declines with successive lines of treatment. This phenomenon is caused by …

Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition

L Lin, Y Sun, D Wang, S Zheng, J Zhang… - Frontiers in …, 2016 - frontiersin.org
Celastrol, also named as tripterine, is a pharmacologically active ingredient extracted from
the root of traditional Chinese herb Tripterygium wilfordii Hook F with potent anti …

[HTML][HTML] Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway

G Wang, CC Feng, SJ Chu… - International …, 2015 - spandidos-publications.com
Abstract AKT/GSK-3β/β-catenin signaling pathway plays an important role in the progression
of colorectal cancer (CRC). Toosendanin (TSN) is a triterpenoid extracted from the bark or …

Celastrol loaded nanoparticles with ROS-response and ROS-inducer for the treatment of ovarian cancer

W Niu, J Wang, Q Wang, J Shen - Frontiers in Chemistry, 2020 - frontiersin.org
Ovarian cancer is a gynecological cancer from which it is difficult to be completely cured. It is
common to use regimens as an effective treatment for ovarian cancer, but these inevitably …

Design, synthesis and evaluation of the novel chalcone derivatives with 2, 2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential

H Xu, J Wang, Y Chen, Y Du, L Chen, C Wu… - European Journal of …, 2023 - Elsevier
Abstract Hypoxia-inducible factor-1 (HIF-1) as a key mediator in tumor metastasis,
angiogenesis and poor patient prognosis, has been recognized as an important cancer drug …

Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway

FF Shang, JY Wang, Q Xu, H Deng, HY Guo… - European Journal of …, 2021 - Elsevier
Four series of hypoxia-inducible factor-1 alpha (HIF-1α) functioning derivatives stemming
from modifications to the C-29 carboxyl group of celastrol were designed and synthesized …

Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile

L Dong, J Deng, ZM Sun, AP Pan, XJ Xiang, L Zhang… - Tumor Biology, 2015 - Springer
Aberrant activation of the Wnt/β-catenin signaling pathway plays a major role in
carcinogenesis and the progression of many malignant tumors, especially gastric cancer …

LKB1 and YAP phosphorylation play important roles in Celastrol-induced β-catenin degradation in colorectal cancer

S Wang, K Ma, C Zhou, Y Wang, G Hu… - Therapeutic …, 2019 - journals.sagepub.com
Wnt/β-catenin and Hippo pathways play essential roles in the tumorigenesis and
development of colorectal cancer. We found that Celastrol, isolated from Tripterygium …